HIGHLIGHTS
- who: Juliana B.T. Carnielli from the York Biomedical Research Institute, Department of Biology, University of York, United Kingdom have published the Article: 3u2032Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine, in the Journal: (JOURNAL)
- what: Implications of all the available evidence the study showed that 3u2032 -nucleotidase/nucleases are the key components of the prognostic marker MSL involved in miltefosine susceptibility. The MSL, highlighted as a promising molecular marker to guide an accurate clinical practice approach, was the focus of this study aimed to investigate the underlying molecular resistance mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.